Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

Elucidating the Impact of Allergen-Specific B Cell Frequency and Affinity on Allergic Reactivity Using Patient-Derived Antibody Sequences in Mouse Models of Peanut Allergy

EF 2019-20

Résumé
Peanut allergy is becoming increasingly common in Canada with serious consequences for Canadians' health. When a person with peanut (PN) allergy ingests PN, they can experience a range of symptoms from discomfort to anaphylaxis, a potentially deadly form of shock. PN allergy is among the most common and severe food allergies, yet it is unknown what drives its development or severity. Allergic symptoms in PN allergy are caused by antibodies. Antibodies are proteins that bind to specific targets with a particular binding strength. They then direct immune responses against their bound target. Antibodies that tightly bind to bacterial or viral proteins protect against infection. However, there are many types of antibodies, not all of which are beneficial. Allergic reactions occur when immunoglobulin E (IgE) type antibodies bind to allergens. Normally, antibody binding strength promotes immune responses, but we have observed the opposite effect for IgE responses. Antibodies are secreted by a type of immune cell called a B cell. Non-activated B cells have antibodies in a receptor form, but only when B cells are activated can they begin to secrete their antibodies. It is not known what activates PN-binding B cells to begin to secrete IgE-type antibodies. I hypothesize that PN-binding IgE responses are promoted when greater numbers of PN-binding B cells with lower PN-binding strength are present. To test this hypothesis, I will use the latest advances in CRISPR-Cas9 genetic editing technology and sequences of PN-binding IgE antibody genes from real PN-allergic patients to generate mice with different amounts and strengths of PN-binding B cells. These mice will then be put through a mouse model of food allergy and the impact of their B cells' PN-binding characteristics will be assessed. This research could reveal why some individuals develop PN allergy and not others and may one day predict the severity of an individual's PN allergy even before it develops.
Programme
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
415420
Name
Wade-Vallance Adam
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Elucidating the Impact of Allergen-Specific B Cell Frequency and Affinity on Allergic Reactivity Using Patient-Derived Antibody Sequences in Mouse Models of Peanut Allergy
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Allergen-Specific B Cell Frequency; Antibody Affinity; B Cell; Flow Cytometry; Ige; Peanut Allergy; Plasma Cell
Abstract
Peanut allergy is becoming increasingly common in Canada with serious consequences for Canadians' health. When a person with peanut (PN) allergy ingests PN, they can experience a range of symptoms from discomfort to anaphylaxis, a potentially deadly form of shock. PN allergy is among the most common and severe food allergies, yet it is unknown what drives its development or severity. Allergic symptoms in PN allergy are caused by antibodies. Antibodies are proteins that bind to specific targets with a particular binding strength. They then direct immune responses against their bound target. Antibodies that tightly bind to bacterial or viral proteins protect against infection. However, there are many types of antibodies, not all of which are beneficial. Allergic reactions occur when immunoglobulin E (IgE) type antibodies bind to allergens. Normally, antibody binding strength promotes immune responses, but we have observed the opposite effect for IgE responses. Antibodies are secreted by a type of immune cell called a B cell. Non-activated B cells have antibodies in a receptor form, but only when B cells are activated can they begin to secrete their antibodies. It is not known what activates PN-binding B cells to begin to secrete IgE-type antibodies. I hypothesize that PN-binding IgE responses are promoted when greater numbers of PN-binding B cells with lower PN-binding strength are present. To test this hypothesis, I will use the latest advances in CRISPR-Cas9 genetic editing technology and sequences of PN-binding IgE antibody genes from real PN-allergic patients to generate mice with different amounts and strengths of PN-binding B cells. These mice will then be put through a mouse model of food allergy and the impact of their B cells' PN-binding characteristics will be assessed. This research could reveal why some individuals develop PN allergy and not others and may one day predict the severity of an individual's PN allergy even before it develops.
Competitiondate
201910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wade-Vallance, Adam
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~